About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 718617, 13 pages
http://dx.doi.org/10.1155/2012/718617
Review Article

Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks

Institute of Pathology, Medical Experimental Centre, Medical Faculty, University of Ljubljana, Zaloška 4, 1105 Ljubljana, Slovenia

Received 9 December 2011; Accepted 5 March 2012

Academic Editor: Oreste Gualillo

Copyright © 2012 Martina Perše and Anton Cerar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Sartor and M. Muehlbauer, “Microbial host interactions in IBD: implications for pathogenesis and therapy,” Current Gastroenterology Reports, vol. 9, no. 6, pp. 497–507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. B. Sartor, “Microbial influences in inflammatory bowel diseases,” Gastroenterology, vol. 134, no. 2, pp. 577–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Xavier and D. K. Podolsky, “Unravelling the pathogenesis of inflammatory bowel disease,” Nature, vol. 448, no. 7152, pp. 427–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. S. Gismera and B. S. Aladren, “Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?” World Journal of Gastroenterology, vol. 14, no. 36, pp. 5491–5498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. J. Zhu, X. Yang, and X. Q. Yu, “Anti-TNF-alpha therapies in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 465898, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Neurath, I. Fuss, and W. Strober, “TNBS-colitis,” International Reviews of Immunology, vol. 19, no. 1, pp. 51–62, 2000. View at Scopus
  7. S. Wirtz and M. F. Neurath, “Mouse models of inflammatory bowel disease,” Advanced Drug Delivery Reviews, vol. 59, no. 11, pp. 1073–1083, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Wirtz, C. Neufert, B. Weigmann, and M. F. Neurath, “Chemically induced mouse models of intestinal inflammation,” Nature Protocols, vol. 2, no. 3, pp. 541–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. De, E. Massi, M. L. Poeta, et al., “The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies,” Journal of Carcinogenesis, vol. 10, article 9, 2011.
  10. M. Kanneganti, M. Mino-Kenudson, and E. Mizoguchi, “Animal models of colitis-associated carcinogenesis,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 342637, 23 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Melgar, L. Karlsson, E. Rehnstrom et al., “Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease,” International Immunopharmacology, vol. 8, no. 6, pp. 836–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ohkusa, “Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora,” Nihon Shokakibyo Gakkai Zasshi, vol. 82, no. 5, pp. 1327–1336, 1985.
  13. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Scopus
  14. S. Melgar, K. Engstrom, A. Jagervall, and V. Martinez, “Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice,” Stress, vol. 11, no. 5, pp. 348–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Mahler, I. J. Bristol, E. H. Leiter et al., “Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis,” American Journal of Physiology, vol. 274, no. 3, part 1, pp. G544–G551, 1998. View at Scopus
  16. T. Vowinkel, T. J. Kalogeris, M. Mori, C. F. Krieglstein, and D. N. Granger, “Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis,” Digestive Diseases and Sciences, vol. 49, no. 4, pp. 556–564, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kitajima, S. Takuma, and M. Morimoto, “Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights,” Experimental Animals, vol. 49, no. 1, pp. 9–15, 2000. View at Scopus
  18. I. Hirono, K. Kuhara, T. Yamaji, S. Hosaka, and L. Golberg, “Carcinogenicity of dextran sulfate sodium in relation to its molecular weight,” Cancer Letters, vol. 18, no. 1, pp. 29–34, 1983. View at Scopus
  19. S. Kitajima, S. Takuma, and M. Morimoto, “Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis,” Journal of Veterinary Medical Science, vol. 61, no. 1, pp. 67–70, 1999. View at Scopus
  20. H. S. Cooper, S. N. Murthy, R. S. Shah, and D. J. Sedergran, “Clinicopathologic study of dextran sulfate sodium experimental murine colitis,” Laboratory Investigation, vol. 69, no. 2, pp. 238–249, 1993. View at Scopus
  21. S. Kitajima, M. Morimoto, and E. Sagara, “A model for dextran sodium sulfate (DSS)-induced mouse colitis: bacterial degradation of DSS does not occur after incubation with mouse cecal contents,” Experimental Animals, vol. 51, no. 2, pp. 203–206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Melgar, A. Karlsson, and E. Michaelsson, “Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation,” American Journal of Physiology, vol. 288, no. 6, pp. G1328–G1338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. L. J. Hall, E. Faivre, A. Quinlan, F. Shanahan, K. Nally, and S. Melgar, “Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis,” Digestive Diseases and Sciences, vol. 56, no. 1, pp. 79–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Talbot, A. Price, and M. Salto-Tellez, Biopsy Pathology in Colorectal Disease, Hadder Arnol, 2nd edition, 2007.
  25. C. M. Fenoglio-Preiser, A. W. Noffsinger, G. N. Stemmermann, P. E. Lantz, and P. G. Isaacson, Gastrointestinal Pathology, LWW, 3rd edition, 2008.
  26. H. Tlaskalova-Hogenova, R. Stepankova, T. Hudcovic, et al., “Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases,” Immunology Letters, vol. 93, no. 2-3, pp. 97–108, 2004.
  27. H. Tlaskalova-Hogenova, L. Tuckova, R. Stepankova, et al., “Involvement of innate immunity in the development of inflammatory and autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1051, pp. 787–798, 2005.
  28. S. Prakash, C. Tomaro-Duchesneau, S. Saha, and A. Cantor, “The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 981214, 12 pages, 2011. View at Publisher · View at Google Scholar
  29. S. Nell, S. Suerbaum, and C. Josenhans, “The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models,” Nature Reviews Microbiology, vol. 8, no. 8, pp. 564–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Hans, J. Scholmerich, V. Gross, and W. Falk, “The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice,” European Journal of Gastroenterology and Hepatology, vol. 12, no. 3, pp. 267–273, 2000. View at Scopus
  31. T. Hudcovic, R. Stepankova, J. Cebra, and H. Tlaskalova-Hogenova, “The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice,” Folia Microbiologica, vol. 46, no. 6, pp. 565–572, 2001. View at Scopus
  32. S. Kitajima, M. Morimoto, E. Sagara, C. Shimizu, and Y. Ikeda, “Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice,” Experimental Animals, vol. 50, no. 5, pp. 387–395, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, “Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis,” Cell, vol. 118, no. 2, pp. 229–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. te Velde, F. de Kort, E. Sterrenburg et al., “Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 13, no. 3, pp. 325–330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Stevceva, P. Pavli, G. Buffinton, A. Wozniak, and W. F. Doe, “Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice,” Journal of Gastroenterology and Hepatology, vol. 14, no. 1, pp. 54–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Ichikawa-Tomikawa, K. Sugimoto, S. Satohisa, K. Nishiura, and H. Chiba, “Possible Involvement of tight junctions, extracellular matrix and nuclear receptors in epithelial differentiation,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 253048, 10 pages, 2011. View at Publisher · View at Google Scholar
  37. P. Laprise, “Emerging role for epithelial polarity proteins of the crumbs family as potential tumor suppressors,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 868217, 9 pages, 2011. View at Publisher · View at Google Scholar
  38. L. S. Poritz, K. I. Garver, C. Green, L. Fitzpatrick, F. Ruggiero, and W. A. Koltun, “Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis,” Journal of Surgical Research, vol. 140, no. 1, pp. 12–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Yan, V. Kolachala, G. Dalmasso et al., “Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis,” PLoS One, vol. 4, no. 6, Article ID e6073, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Mennigen, K. Nolte, E. Rijcken et al., “Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis,” American Journal of Physiology, vol. 296, no. 5, pp. G1140–G1149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Araki, K. Mukaisyo, H. Sugihara, Y. Fujiyama, and T. Hattori, “Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice,” Oncology Reports, vol. 24, no. 4, pp. 869–874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Egger, M. Bajaj-Elliott, T. T. MacDonald, R. Inglin, V. E. Eysselein, and M. W. Büchler, “Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency,” Digestion, vol. 62, no. 4, pp. 240–248, 2000. View at Scopus
  43. P. Alex, N. C. Zachos, T. Nguyen et al., “Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis,” Inflammatory Bowel Diseases, vol. 15, no. 3, pp. 341–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Sullivan, P. Alex, T. Dassopoulos et al., “Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea,” Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 261–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Lu, S. M. Fernandes, and A. E. Davis III, “The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease,” American Journal of Physiology, vol. 298, no. 6, pp. G878–G883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. P. López, C. Gutiérrez, and A. Suárez, “IL-10 and TNFalpha genotypes in SLE,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 838390, 11 pages, 2010. View at Publisher · View at Google Scholar
  47. B. Marshall and S. Swain, “Cytotoxic CD4 T cells in antiviral immunity,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 954602, 8 pages, 2011. View at Publisher · View at Google Scholar
  48. P. K. Yadav, C. Chen, and Z. Liu, “Potential role of NK cells in the pathogenesis of inflammatory bowel disease,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 348530, 6 pages, 2011. View at Publisher · View at Google Scholar
  49. P. L. Beck, R. Xavier, J. Wong et al., “Paradoxical roles of different nitric oxide synthase isoforms in colonic injury,” American Journal of Physiology, vol. 286, no. 1, pp. G137–G147, 2004. View at Scopus
  50. P. L. Beck, Y. Li, J. Wong et al., “Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation,” Gastroenterology, vol. 132, no. 5, pp. 1778–1790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Naito, T. Takagi, O. Handa et al., “Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice,” Journal of Gastroenterology and Hepatology, vol. 18, no. 5, pp. 560–569, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Kawada, A. Arihiro, and E. Mizoguchi, “Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease,” World Journal of Gastroenterology, vol. 13, no. 42, pp. 5581–5593, 2007. View at Scopus
  53. M. M. Heimesaat, A. Fischer, B. Siegmund et al., “Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via toll-like receptors 2 and 4,” PLoS One, vol. 2, no. 7, article e662, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Fukata, K. S. Michelsen, R. Eri et al., “Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis,” American Journal of Physiology, vol. 288, no. 5, pp. G1055–G1065, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Araki, T. Kanai, T. Ishikura et al., “MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis,” Journal of Gastroenterology, vol. 40, no. 1, pp. 16–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Hoshino, Y. Kawase, M. Okamoto et al., “Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function,” Journal of Immunology, vol. 166, no. 12, pp. 7014–7018, 2001. View at Scopus
  57. T. Ishikura, T. Kanai, K. Uraushihara et al., “Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice,” Journal of Gastroenterology and Hepatology, vol. 18, no. 8, pp. 960–969, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Yoshihara, T. Yajima, C. Kubo, and Y. Yoshikai, “Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice,” Gut, vol. 55, no. 3, pp. 334–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. H. T. Ten, P. Drillenburg, J. Wijnholds, A. A. te Velde, and S. J. H. van Deventer, “Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis,” Digestive Diseases and Sciences, vol. 47, no. 9, pp. 2056–2063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. J. A. Martinez, C. S. Williams, J. M. Amann et al., “Deletion of mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis,” Gastroenterology, vol. 131, no. 2, pp. 579–588, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Horino, M. Fujimoto, F. Terabe et al., “Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice,” International Immunology, vol. 20, no. 6, pp. 753–762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. E. E. Mannick, R. L. Cote, J. R. Schurr et al., “Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice,” Journal of Gastroenterology and Hepatology, vol. 20, no. 3, pp. 371–380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Adachi, R. Kurotani, K. Morimura et al., “Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease,” Gut, vol. 55, no. 8, pp. 1104–1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. A. J. Guri, S. K. Mohapatra, W. T. Horne, R. Hontecillas, and J. Bassaganya-Riera, “The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease,” BMC Gastroenterology, vol. 10, article 60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. J. E. Ghia, N. Li, H. Wang et al., “Serotonin has a key role in pathogenesis of experimental colitis,” Gastroenterology, vol. 137, no. 5, pp. 1649–1660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Fayad, M. Pini, J. A. Sennello et al., “Adiponectin deficiency protects mice from chemically induced colonic inflammation,” Gastroenterology, vol. 132, no. 2, pp. 601–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Nishihara, M. Matsuda, H. Araki et al., “Effect of adiponectin on murine colitis induced by dextran sulfate sodium,” Gastroenterology, vol. 131, no. 3, pp. 853–861, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. M. Shah, S. Ito, K. Morimura et al., “Hypoxia-inducible factor augments experimental colitis through an mif-dependent inflammatory signaling cascade,” Gastroenterology, vol. 134, no. 7, pp. 2036–2048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Takagi, T. Kanai, A. Okazawa et al., “Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice,” Scandinavian Journal of Gastroenterology, vol. 38, no. 8, pp. 837–844, 2003. View at Publisher · View at Google Scholar · View at Scopus